CARDIOVASCULAR SYSTEMS, INC. — Operating Income by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/d5548e9a-0f3d-44b5-8d57-2f5b441eac58/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2022 | $-35.8M | 2021-07-01 – 2022-06-30 | evidence 0001180145-22-000038 |
| FY 2021 | $-11.9M | 2020-07-01 – 2021-06-30 | evidence 0001180145-21-000032 |
| FY 2020 | $-26.8M | 2019-07-01 – 2020-06-30 | evidence 0001180145-20-000042 |
| FY 2019 | $-825.0k | 2018-07-01 – 2019-06-30 | evidence 0001180145-19-000028 |
| FY 2018 | $2.2M | 2017-07-01 – 2018-06-30 | evidence 0001180145-18-000044 |
| FY 2017 | $-1.5M | 2016-07-01 – 2017-06-30 | evidence 0001180145-17-000040 |
| FY 2016 | $-56.1M | 2015-07-01 – 2016-06-30 | evidence 0001180145-16-000096 |
| FY 2015 | $-32.6M | 2014-07-01 – 2015-06-30 | evidence 0001180145-15-000026 |
| FY 2014 | $-33.5M | 2013-07-01 – 2014-06-30 | evidence 0001180145-14-000030 |
| FY 2013 | $-22.4M | 2012-07-01 – 2013-06-30 | evidence 0001445305-13-002256 |
| FY 2012 | $-14.5M | 2011-07-01 – 2012-06-30 | evidence 0001193125-12-386811 |
| FY 2011 | $-8.8M | 2010-07-01 – 2011-06-30 | evidence 0001193125-12-386811 |
| FY 2010 | $-22.9M | 2009-07-01 – 2010-06-30 | evidence 0001193125-12-386811 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
CARDIOVASCULAR SYSTEMS, INC. — all facts · Revenue · Net Income